These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 24147047

  • 1. Relationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillation.
    Li Y, Ding W, Wang H, Song N, Lin L, Wang Z, Zhong M, Zhang Y, Zhang W.
    PLoS One; 2013; 8(10):e77653. PubMed ID: 24147047
    [Abstract] [Full Text] [Related]

  • 2. Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores.
    Akamatsu K, Ito T, Ozeki M, Miyamura M, Sohmiya K, Hoshiga M.
    Cardiovasc Ultrasound; 2020 Aug 01; 18(1):31. PubMed ID: 32738924
    [Abstract] [Full Text] [Related]

  • 3. Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation.
    Chen YY, Liu Q, Liu L, Shu XR, Su ZZ, Zhang HF, Nie RQ, Wang JF, Xie SL.
    Chin Med J (Engl); 2016 Oct 20; 129(20):2395-2402. PubMed ID: 27748329
    [Abstract] [Full Text] [Related]

  • 4. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA2 DS2 -VASc score: Study based on transesophageal echocardiography and 2-dimensional speckle tracking.
    Zuo K, Sun L, Yang X, Lyu X, Li K.
    Clin Cardiol; 2017 Feb 20; 40(2):120-125. PubMed ID: 28075503
    [Abstract] [Full Text] [Related]

  • 5. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
    Azarbal F, Welles CC, Wong JM, Whooley MA, Schiller NB, Turakhia MP.
    Am J Cardiol; 2014 Apr 01; 113(7):1166-72. PubMed ID: 24507169
    [Abstract] [Full Text] [Related]

  • 6. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Apr 01; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 7. Association of CHADS2 and CHA2DS2-VASc Scores with Left Atrial Thrombus with Nonvalvular Atrial Fibrillation: A Single Center Based Retrospective Study in a Cohort of 2695 Chinese Subjects.
    Huang J, Wu SL, Xue YM, Fei HW, Lin QW, Ren SQ, Liao HT, Zhan XZ, Fang XH, Xu L.
    Biomed Res Int; 2017 Apr 01; 2017():6839589. PubMed ID: 28373985
    [Abstract] [Full Text] [Related]

  • 8. Relationship between CHA2DS2-VASc score and atrial electromechanical function in patients with paroxysmal atrial fibrillation: A pilot study.
    Vatan MB, Yılmaz S, Ağaç MT, Çakar MA, Erkan H, Aksoy M, Demirtas S, Varım C, Akdemir R, Gündüz H.
    J Cardiol; 2015 Nov 01; 66(5):382-7. PubMed ID: 25818642
    [Abstract] [Full Text] [Related]

  • 9. The Value of the CHADS2 and CHA2DS2-VASc Score for Predicting the Prognosis in Lacunar Stroke with or without Atrial Fibrillation Patients.
    Yang HJ, Wang GJ, Shuai W, Shen CJ, Kong B, Huang H.
    J Stroke Cerebrovasc Dis; 2019 Nov 01; 28(11):104143. PubMed ID: 31477449
    [Abstract] [Full Text] [Related]

  • 10. Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the CHADS2 and CHA2DS2-VASc Scores.
    Kim MN, Kim SA, Choi JI, Park SM, Park SW, Kim YH, Shim WJ.
    Int Heart J; 2015 May 13; 56(3):286-92. PubMed ID: 25912904
    [Abstract] [Full Text] [Related]

  • 11. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.
    Europace; 2014 Feb 13; 16(2):202-7. PubMed ID: 23813452
    [Abstract] [Full Text] [Related]

  • 12. Relation of red blood cell distribution width with CHADS2 and CHA2DS2-VASc score in Chinese patients with non-valvular atrial fibrillation.
    Liu T, Shao Q, Korantzopoulos P, Miao S, Zhang Z, Xu G, Yuan R, Li G.
    Int J Cardiol; 2017 Feb 01; 228():861-864. PubMed ID: 27889552
    [Abstract] [Full Text] [Related]

  • 13. Refinement of CHADS2 and CHA2DS2-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients.
    Cao M, Guo H, Zhao X, Li X, Sun C.
    J Int Med Res; 2022 Jan 01; 50(1):3000605221074520. PubMed ID: 35196885
    [Abstract] [Full Text] [Related]

  • 14. Association of the CHADS2 and CHA 2DS 2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients.
    Hrynkiewicz-Szymanska A, Dluzniewski M, Platek AE, Szymanski FM, Syska-Suminska J, Klos-Szadryn A, Glinka M, Strojek M, Kuciej A, Tomaszewska-Kiecana M.
    J Thromb Thrombolysis; 2015 Aug 01; 40(2):240-7. PubMed ID: 25490871
    [Abstract] [Full Text] [Related]

  • 15. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr 01; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 16. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct 01; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 17. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.
    Katz DF, Maddox TM, Turakhia M, Gehi A, O'Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu JC.
    Circ Cardiovasc Qual Outcomes; 2017 May 01; 10(5):. PubMed ID: 28506981
    [Abstract] [Full Text] [Related]

  • 18. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF.
    Atherosclerosis; 2014 Dec 01; 237(2):504-13. PubMed ID: 25463082
    [Abstract] [Full Text] [Related]

  • 19. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T, Sato Y, Ozawa M, Kunugita F, Yoshizawa R, Morino Y, Nakamura M.
    Int Heart J; 2014 Dec 01; 55(2):119-25. PubMed ID: 24632957
    [Abstract] [Full Text] [Related]

  • 20. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.
    Thromb Haemost; 2012 Jun 01; 107(6):1172-9. PubMed ID: 22473219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.